Skip to main content

Ad Scientiam selected for Pfizer Acceleration Program

Pfizer has selected Ad Scientiam for its Acceleration Program in the Brain and Spine Institute and Station F.

 

https://business.lesechos.fr/entrepreneurs/communaute/0600581731304-lucine-semeia-kiwifab-et-ad-scientam-seront-accompagnees-par-pfizer-326567.php

 

 

 

Latest News

No news available.